Sucampo Pharmaceuticals, Inc. (SCMP) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Sucampo Pharmaceuticals, Inc., Reports First Quarter 2014 Financial and Operating Results
May 7, 2014 4:02 PM EDTStrong Financial Performance Driven by Year over Year Income and Revenue Growth
Company to host conference call today at 5:00 pm Eastern
BETHESDA, Md., May 7, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq: SCMP) today reported consolidated financial results for the first quarter ended March 31, 2014. Sucampo reported year over year revenue growth of 31% and fully-diluted earnings per share of $0.02 during the first quarter of 2014.
"I am pleased with the progress Sucampo made in the first quarter," said Peter Greenleaf, Chief Executive... More
